Q2 2024 13F Holders as of 30 Jun 2024
-
Type / Class
-
Equity / GENOMIC REV ETF
-
Total 13F shares
-
22,680,631
-
Share change
-
+1,795,209
-
Total reported value
-
$532,966,671
-
Put/Call ratio
-
236%
-
Price per share
-
$23.48
-
Number of holders
-
258
-
Value change
-
+$39,117,310
-
Number of buys
-
76
-
Number of sells
-
138
Institutional Holders of ARK ETF TR - GENOMIC REV ETF (ARKG) as of Q2 2024
As of 30 Jun 2024,
ARK ETF TR - GENOMIC REV ETF (ARKG) was held by
258 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
22,680,631 shares.
The largest 10 holders included
Main Management ETF Advisors, LLC, BNP PARIBAS FINANCIAL MARKETS, JPMORGAN CHASE & CO, UBS Group AG, MORGAN STANLEY, BANK OF AMERICA CORP /DE/, WELLS FARGO & COMPANY/MN, LPL Financial LLC, GOLDMAN SACHS GROUP INC, and CITIGROUP INC.
This page lists
257
institutional shareholders reporting positions in this security
for the Q2 2024 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.